CITRAVESCENT granules sachet (reformulation)

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

sodium bicarbonate, Quantity: 1.32 g; citric acid, Quantity: 1.23 g; tartaric acid, Quantity: 0.4 g; sodium carbonate, Quantity: 0.08 g

から入手可能:

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

INN（国際名）:

citric acid,sodium bicarbonate,sodium carbonate,tartaric acid

医薬品形態:

Granules, effervescent

構図:

Excipient Ingredients: lactose monohydrate; sucrose

投与経路:

Oral

パッケージ内のユニット:

8 sachets, 10 sachets, 25 sachets, 28 sachets, 20 sachets

処方タイプ:

Not scheduled. Not considered by committee

適応症:

Systemic and urinary alkalinisation where indicated in the relief of symptoms associated with urinary tract infections such as cystitis, pyelonephritis, urethritis; and in reducing the formation of uric acid and cystine calculi. Citravescent may increase the effectiveness of sulphonamide antibiotics in the treatment of urinary tract infection. Acid indigestion or heartburn.

製品概要:

Visual Identification: White granules; Container Type: Sachet; Container Material: Al laminated with LDPE/paper; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

認証ステータス:

Licence status A

承認日:

2013-08-15